Single-Dose Basiliximab Induction Therapy in Low-Immunologic Risk Kidney Transplant Recipients

被引：0
|
作者：
Hutchins, A. [1 ]
Schoen, J. [1 ]
McMullen, J. S. [1 ]
机构：
[1] Nebraska Med, Pharm, Omaha, NE USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2021年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
280
引用
收藏
页码：433 / 434
页数：2
相关论文
共 50 条
  • [41] Basiliximab vs. Low-Dose Thymoglobulin Induction Therapy in Low Risk Kidney Transplant Patients: Prospective Randomized Study in Southeastern Mexico.
    Martinez-Mier, G.
    Moreno-Ley, P. I.
    Budar-Fernandez, L. F.
    Mendez-Lopez, M. T.
    Barrera-Amoros, D. A.
    De la Paz-Roman, M.
    Jimenez-Lopez, L. A.
    Aguilar-Sandoval, E. G.
    Allende-Castellanos, C. A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 822 - 823
  • [42] Single Fixed Low Dose of Rituximab as Induction Therapy for Kidney Transplant Recipients Highly Sensitized with Donor-Specific Antibodies
    Tomita, Y.
    Iwadoh, K.
    Nakajima, I.
    Fuchinoue, S.
    Koyama, I.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 281 - 281
  • [43] Basiliximab versus T-cell Depleting Induction Therapy in Elderly Kidney Transplant Recipients.
    Vranic, G.
    Shah, H.
    Thomas, B.
    Javaid, B.
    Moore, J.
    Cooper, M.
    Gilbert, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 560 - 561
  • [44] Low-Dose Rabbit Antithymocyte Globulin Induction in Elderly Kidney Transplant Recipients at High Immunologic Risk is Safe and May Prevent Excess Rejection
    Sartain, E.
    Nettles, B.
    Crowther, B.
    Klem, P.
    Schwarz, K.
    Davis, S.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 903 - 903
  • [45] Induction Therapy with Low-Dose Rituximab Could Be a Risk Factor of BKV Associated Nephropathy in Kidney Transplant Recipients.
    Murakami, R.
    Nagawa, D.
    Nakata, M.
    Narita, I.
    Fujita, T.
    Shimada, M.
    Nakamura, N.
    Tomita, H.
    Hatakeyama, S.
    Yoneyama, T.
    Hashimoto, Y.
    Koie, T.
    Ohyama, C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 831 - 831
  • [46] Induction Therapy in Low Risk African American Kidney Transplant Recipients: Donor Factors.
    Al Ammary, F.
    Bae, S.
    Massie, A.
    Dagher, N.
    King, E.
    Wiseman, A.
    Segev, D.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 618 - 619
  • [47] CMV VIREMIA IN KIDNEY TRANSPLANT RECIPIENTS RECEIVING BASILIXIMAB OR LOW DOSE ANTI THYMOCYTE GLOBULIN INDUCTION WITHOUT VALGANCICLOVIR PROPHYLAXIS- SINGLE CENTRE EXPERIENCE IN INDIA
    Sharma, Reetesh
    Maksana, Mayur
    Trehan, Naresh
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 2091 - 2091
  • [48] Low-Dose Rabbit Antithymocyte Globulin Versus Basiliximab Induction Therapy in Low-Risk Renal Transplant Recipients: 8-Year Follow-Up
    Laftavi, M. R.
    Alnimri, M.
    Weber-Shrikant, E.
    Kohli, R.
    Said, M.
    Patel, S.
    Pankewycz, O.
    [J]. TRANSPLANTATION PROCEEDINGS, 2011, 43 (02) : 458 - 461
  • [49] BENEFICIAL EFFECT OF INDUCTION THERAPY BY BASILIXIMAB IN LIVER TRANSPLANT HIGH RISK RECIPIENTS WITH POOR RENAL FUNCTION
    Ichai, Delvart P.
    Kouassi, M.
    Antonini, T. M.
    Roche, B.
    Azoulay, D.
    Adam, R.
    Castaing, D.
    Samuel, D.
    [J]. LIVER TRANSPLANTATION, 2009, 15 (07) : S133 - S133
  • [50] Excellent antirejection prophylaxis and low incidence of infections after kidney transplant with low dose rabbit antithymocyte globulin induction therapy in high immunologic risk patients
    Baron, Pedro W.
    Infante, Sergio
    Weissman, Jill
    Karmanova, Marina
    Kore, Arputharaj
    Wai, Philip
    Beeson, Lawrence
    de Vera, Michael
    [J]. TRANSPLANTATION, 2016, 100 (07) : S697 - S697
12345